4/1/2026Pierre Fabre Deepens China Commitment as Pharma and Dermo-Cosmetics Gr...

4/1/2026China Tightens Health Insurance Fund Oversight With New Anti-Fraud Rul...

4/1/2026Alphamab and CSPC Win Phase III Breast Cancer Success for KN026 Neo-He...

3/31/2026Simcere Highlights Late-Breaking Phase III Success for Rademikibart in...

3/31/2026Innovent Publishes Strong Phase II Mazdutide 9 mg Obesity Data as Chin...

3/31/2026Braveheart Bio Posts Promising Mid-Stage China Data for HCM Drug Licen...

3/31/2026Connect Biopharma Reports Promising Late-Stage China Results for Eczem...

3/31/2026Huahui Launches World's First Approved Hepatitis D Antibody Drug in Ch...

3/31/2026NMPA Moves to Strengthen China's Conditional Drug Approval Framework

3/31/2026NHSA Deepens Dialogue With MNC Pharma on Innovation Drug Value and Rea...

3/31/2026IMPACT Therapeutics Renews Hong Kong IPO Push With Updated Filing

3/30/2026GSK's Exdensur Wins China Approval for Severe Eosinophilic Asthma

3/30/2026AZ/Amgen's Tezspire Wins China Approval for Asthma and CRSwNP

3/30/2026Almirall Partners Shanghai Huaota in $340 Million Dermatology Antibody...

3/30/2026China Approves Claruvis's Retoxin, Marking New Milestone in Recombinan...

3/30/2026BioRay and UCB Win Dual China Dermatology Approvals for Bimzelx

3/30/2026Enhertu Wins First Global Approval in Neoadjuvant HER2-Positive Early ...

3/27/2026China Pharma Market Set for Structural Shift as Innovation and Cost Pr...

3/27/2026GSK Partners Shanghai Pharma to Reintroduce Hepatitis B Vaccine in Chi...

3/27/2026SK Biopharma Launches Epilepsy Drug Cenobamate in China

3/27/2026Recent Executive Moves

3/25/2026Hope Medicine Advances HMI-115 Into Phase III for Endometriosis

3/25/2026Innovent Reports Positive Phase 3 STAR Results for IBI302 in nAMD

3/25/2026Gilead Nears $2B Ouro Deal Anchored by China-Origin BCMA/CD3 Asset

3/25/2026BrightGene Reports Positive Phase 1 Data for Oral GLP-1/GIP Weight-Los...

3/25/2026China Suspends Imports of Select Indian APIs Over GMP Violations

3/25/2026Innovent Eyes China Approval as IBI302 Matches Eylea in Phase 3 nAMD S...

3/25/2026IQVIA Report Highlights Rising Use and Intensifying Competition in Chi...

3/24/2026Global Pharma Ramps Up China Investment as 15th Five-Year Plan Priorit...

3/24/2026Novartis Commits $480M to Expand China Footprint

Page:1/383 Total number of articles:11483: [First][<<] [1] [2] [3] [4] [5] [>>] [End]